David J. Katzoff - Jun 14, 2021 Form 3 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Chief Operating Officer
Signature
/s/ David J. Katzoff
Stock symbol
ALZN
Transactions as of
Jun 14, 2021
Transactions value $
$0
Form type
3
Date filed
6/14/2021, 07:55 PM
Next filing
Dec 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ALZN Common Stock 18K Jun 14, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ALZN Warrants Jun 14, 2021 Common Stock 9K $3.00 Direct
holding ALZN Stock Options (Right to Buy) Jun 14, 2021 Common Stock 400K $1.00 Direct F1
holding ALZN Stock Options (Right to Buy) Jun 14, 2021 Common Stock 850K $1.50 Direct F2
holding ALZN Stock Options (Right to Buy) Jun 14, 2021 Common Stock 250K $1.50 Direct F3
holding ALZN Stock Options (Right to Buy) Jun 14, 2021 Common Stock 1M $1.50 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests ratably over forty-eight (48) months commencing after January 20, 2019.
F2 Vests quarterly over sixteen (16) quarters commencing after October 31, 2019.
F3 Vests quarterly over sixteen (16) quarter commencing after November 25, 2019.
F4 Vests based upon certain performance criteria. Of these options, none shares of Common Stock are vested and exercisable.